208 related articles for article (PubMed ID: 34675064)
1. Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer.
Hemani R; Patel I; Inamdar N; Campanelli G; Donovan V; Kumar A; Levenson AS
Cancer Prev Res (Phila); 2022 Feb; 15(2):87-100. PubMed ID: 34675064
[TBL] [Abstract][Full Text] [Related]
2. Gnetin C Intercepts MTA1-Associated Neoplastic Progression in Prostate Cancer.
Parupathi P; Campanelli G; Deabel RA; Puaar A; Devarakonda LS; Kumar A; Levenson AS
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551523
[TBL] [Abstract][Full Text] [Related]
3. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer.
Dhar S; Kumar A; Zhang L; Rimando AM; Lage JM; Lewin JR; Atfi A; Zhang X; Levenson AS
Oncotarget; 2016 Apr; 7(14):18469-84. PubMed ID: 26943043
[TBL] [Abstract][Full Text] [Related]
4. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS
Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573
[TBL] [Abstract][Full Text] [Related]
5. Grape Powder Supplementation Attenuates Prostate Neoplasia Associated with Pten Haploinsufficiency in Mice Fed High-Fat Diet.
Joshi T; Patel I; Kumar A; Donovan V; Levenson AS
Mol Nutr Food Res; 2020 Aug; 64(16):e2000326. PubMed ID: 32618118
[TBL] [Abstract][Full Text] [Related]
6. Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy.
Levenson AS
Semin Cancer Biol; 2022 May; 80():107-117. PubMed ID: 32126261
[TBL] [Abstract][Full Text] [Related]
7. MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer.
Kumar A; Dholakia K; Sikorska G; Martinez LA; Levenson AS
Nutrients; 2019 Sep; 11(9):. PubMed ID: 31487842
[TBL] [Abstract][Full Text] [Related]
8. Dietary stilbenes as modulators of specific miRNAs in prostate cancer.
Levenson AS
Front Pharmacol; 2022; 13():970280. PubMed ID: 36091792
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice.
Banach-Petrosky W; Ouyang X; Gao H; Nader K; Ji Y; Suh N; DiPaola RS; Abate-Shen C
Clin Cancer Res; 2006 Oct; 12(19):5895-901. PubMed ID: 17020998
[TBL] [Abstract][Full Text] [Related]
10. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer.
Li K; Dias SJ; Rimando AM; Dhar S; Mizuno CS; Penman AD; Lewin JR; Levenson AS
PLoS One; 2013; 8(3):e57542. PubMed ID: 23469203
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Anticancer Properties of Table Grape Powder Extract (GPE) in Prostate Cancer.
Kumar A; D'silva M; Dholakia K; Levenson AS
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30463302
[TBL] [Abstract][Full Text] [Related]
12. The Therapeutic Efficacy and Mechanism of Action of Gnetin C, a Natural Compound from the Melinjo Plant, in a Preclinical Mouse Model of Advanced Prostate Cancer.
Campanelli G; Francois E; Parupathi P; Devarakonda LS; Yang C; Kumar A; Levenson AS
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611022
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer.
Dhar S; Kumar A; Li K; Tzivion G; Levenson AS
Biochim Biophys Acta; 2015 Feb; 1853(2):265-75. PubMed ID: 25447541
[TBL] [Abstract][Full Text] [Related]
14. MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities.
Levenson AS; Kumar A; Zhang X
Cancer Metastasis Rev; 2014 Dec; 33(4):929-42. PubMed ID: 25332143
[TBL] [Abstract][Full Text] [Related]
15. Pterostilbene inhibits MTA1/HDAC1 complex leading to PTEN acetylation in hepatocellular carcinoma.
Qian YY; Liu ZS; Yan HJ; Yuan YF; Levenson AS; Li K
Biomed Pharmacother; 2018 May; 101():852-859. PubMed ID: 29635894
[TBL] [Abstract][Full Text] [Related]
16. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.
Luchman HA; Benediktsson H; Villemaire ML; Peterson AC; Jirik FR
PLoS One; 2008; 3(12):e3940. PubMed ID: 19081794
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer.
Dhar S; Kumar A; Rimando AM; Zhang X; Levenson AS
Oncotarget; 2015 Sep; 6(29):27214-26. PubMed ID: 26318586
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention for prostatic intraepithelial neoplasia.
Nelson PS; Gleason TP; Brawer MK
Eur Urol; 1996; 30(2):269-78. PubMed ID: 8875211
[TBL] [Abstract][Full Text] [Related]
19. Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials.
Bostwick DG; Aquilina JW
J Cell Biochem Suppl; 1996; 25():156-64. PubMed ID: 9027613
[TBL] [Abstract][Full Text] [Related]
20. Opposing effects of androgen deprivation and targeted therapy on prostate cancer prevention.
Jia S; Gao X; Lee SH; Maira SM; Wu X; Stack EC; Signoretti S; Loda M; Zhao JJ; Roberts TM
Cancer Discov; 2013 Jan; 3(1):44-51. PubMed ID: 23258246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
